About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - INVION LIMITED
INVION LIMITED
Health Care
Invion Limited (IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein. Former Names Cbio Limited (CBZ), 04/09/2012.
Read moreMarket Cap
60.54m
Price at Close
$0.011
4w avg. Volume
821.26k
4w avg. Turnover
$8.57k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| 0.00% | 28 Oct 2020 |
| 0.00% | 28 Oct 2020 |
| 0.00% | 28 Oct 2020 |
| -9.09% | 27 Oct 2020 |
| -9.09% | 27 Oct 2020 |
| 0.00% | 25 Oct 2020 |
| 0.00% | 25 Oct 2020 |
| 0.00% | 21 Oct 2020 |
| 0.00% | 21 Oct 2020 |
| 0.00% | 20 Sep 2020 |
Market Data
Current Price
$0.011
52WK HIGH
$0.026
52WK LOW
$0.006
1YR RETURN
-15.38%
1YR RETURN VS. SECTOR
-30.77%
90 DAY RETURN
+22.22%
ASX RANK
975
/2,013
SECTOR RANK
12
/30
SHARES OUTSTANDING
5.50b
INVION LIMITED
Health Care
Invion Limited (IVX) is a clinical-stage drug development company in the biotechnology and pharmaceutical industry in Australia. IVX has three key development programs: INV102 for inflammatory respiratory disease; INV104, a leukotriene receptor antagonist; and, INV103, a modified, naturally occurring human protein. Former Names Cbio Limited (CBZ), 04/09/2012.
Read moreMarket Cap
60.54m
Price at Close
$0.011
4w avg. Volume
821.26k
4w avg. Turnover
$8.57k
ASX:IVX is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia